Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| DOV | 8-K | bullish | 6/10 | Dover Corp reported Q3 2026 results with revenue of $2.23B (+8% YoY, +7% organic) and adjusted diluted EPS of $2.88 (+10 | Oct 22, 2026 |
| BPOP | 8-K | neutral | 5/10 | Popular, Inc. reported Q3 2026 EPS of $4.21, a 1.2% beat vs consensus of $4.16, but net income fell 4% sequentially to $ | Oct 22, 2026 |
| UTHR | 8-K | neutral | 4/10 | United Therapeutics announced a $2.0 billion share repurchase authorization, effective through October 21, 2027. The com | Oct 22, 2026 |
| FPS | 8-K | neutral | 3/10 | Forgent Power Solutions CFO Ryan Fiedler stepped down effective October 21, 2026, and will depart on October 30, 2026, a | Oct 22, 2026 |
| AAL | 8-K | bearish | 6/10 | American Airlines reported record Q3 2026 revenue of $16.3B (+19.3% YoY), above the high end of guidance, but posted a G | Oct 22, 2026 |
| BHVN | 8-K | bullish | 6/10 | Biohaven announced that the FDA accepted for review its resubmitted NDA for troriluzole (Vyglxia) in spinocerebellar ata | Oct 22, 2026 |
| DOW | 8-K | bullish | 6/10 | Dow Inc. reported Q3 2026 net sales of $11.27B (+13% YoY) and GAAP EPS of $0.62, with operating EPS of $0.71 versus cons | Oct 22, 2026 |
| LHX | 8-K | neutral | 2/10 | L3Harris appointed Kimberly Fields, Chair, President and CEO of ATI, Inc., as an independent director, expanding the boa | Oct 22, 2026 |
| BFH | 8-K | neutral | 4/10 | Bread Financial released a monthly performance update for September 2026, showing improving credit trends. The delinquen | Oct 22, 2026 |
| R | 8-K | bullish | 6/10 | Ryder reported Q3 2026 comparable EPS of $4.33, a 1.8% beat vs consensus of $4.25, and total revenue of $3.433B (+8% YoY | Oct 22, 2026 |
| GRNQ | 8-K | neutral | 3/10 | Greenpro Capital Corp. disclosed the resignation of board member Prabodh Kumar Kantilal H Sheth, effective October 31, 2 | Oct 22, 2026 |
| BX | 8-K | mixed | 5/10 | Blackstone reported Q3 2026 Distributable Earnings of $1.7B ($1.32/share), a 4.9% beat vs consensus of $1.26, but down 9 | Oct 22, 2026 |
| DGX | 8-K | neutral | 4/10 | Quest Diagnostics disclosed unauthorized access to its Quanum LSM system on October 21, 2026, potentially involving pati | Oct 22, 2026 |
| KTB | 8-K | neutral | 2/10 | Kontoor Brands declared a regular quarterly cash dividend of $0.54 per share, a 2% increase from the prior $0.53, payabl | Oct 22, 2026 |
| DAR | 8-K | bullish | 6/10 | Darling Ingredients issued a pre-earnings statement providing FY2026 Combined Adjusted EBITDA guidance of $2.2-$2.3 bill | Oct 22, 2026 |
| DGX | 8-K | bullish | 7/10 | Quest Diagnostics reported Q3 2026 revenue of $3.097B (+10.0% YoY) and adjusted diluted EPS of $3.00, beating consensus | Oct 22, 2026 |
| BSTT | 8-K | neutral | 4/10 | BREIT reported preliminary estimated same property NOI for Q3 2026 YTD increased approximately 3% YoY, consistent with t | Oct 22, 2026 |
| BFH | 8-K | bullish | 6/10 | Bread Financial reported Q3 2026 adjusted EPS of $3.84, beating consensus of $3.23 by 18.8%, on revenue of $1.017B vs $1 | Oct 22, 2026 |
| LNN | 8-K | neutral | 5/10 | Lindsay Corp reported Q4 FY2026 revenue of $161.6M (+5% YoY) and diluted EPS of $1.10 (+11% YoY), beating consensus esti | Oct 22, 2026 |
| CURB | 8-K | neutral | 5/10 | Curbline Properties reported Q3 2026 Operating FFO of $0.32 per diluted share, in line with consensus of $0.32, and tota | Oct 22, 2026 |
| SNA | 8-K | bearish | 6/10 | Snap-on reported Q3 2026 net sales of $1,183.7M (-0.6% YoY) and diluted EPS of $4.64, a 10.4% miss vs consensus of $5.18 | Oct 22, 2026 |
| AMAL | 8-K | bullish | 6/10 | Amalgamated Financial Corp. reported record Q3 2026 net income of $36.4M ($1.20 GAAP diluted EPS; $1.14 core diluted EPS | Oct 22, 2026 |
| VREX | 8-K | neutral | 4/10 | Varex Imaging filed an 8-K providing supplemental disclosures to its definitive proxy statement for the pending merger w | Oct 22, 2026 |
| LAZ | 8-K | mixed | 5/10 | Lazard reported Q3 2026 adjusted EPS of $0.36, a 36% YoY decline and a 16% miss vs the $0.43 consensus, while adjusted n | Oct 22, 2026 |
| IIIN | 8-K | bearish | 6/10 | Insteel Industries reported Q4 fiscal 2026 EPS of $0.40, missing the $0.49 consensus, and revenue of $209.3M, above the | Oct 22, 2026 |
| LMT | 8-K | mixed | 6/10 | Lockheed Martin reported Q3 2026 EPS of $7.97, missing consensus estimates of $8.56 by 6.9%, while revenue of $20.7B als | Oct 22, 2026 |
| HBAN | 8-K | bearish | 5/10 | Huntington Bancshares reported Q3 2026 GAAP diluted EPS of $0.33, flat QoQ but down from $0.41 a year ago. Adjusted EPS | Oct 22, 2026 |
| GLND | 8-K | neutral | 2/10 | Board member Roderick McIllree resigned effective immediately on October 20, 2026, with no disagreement cited. The filin | Oct 22, 2026 |
| THRM | 8-K | bearish | 6/10 | Gentherm reported Q3 2026 revenue of $405.1M (+4.7% YoY), slightly above consensus of $402.7M, but GAAP EPS of -$0.08 an | Oct 22, 2026 |
| CGTX | 8-K | bullish | 7/10 | Cognition Therapeutics announced FDA alignment on key elements of a pivotal Phase 3 trial of zervimesine (CT1812) in dem | Oct 22, 2026 |